125 related articles for article (PubMed ID: 7807175)
21. Ventriculolumber perfusion of 3-[(4-amino-2-methyl-5-pyrimidinyl)-methyl]-1-(2-chloroethyl-1-nitrosou rea hydrochloride for subarachnoid dissemination of gliomas.
Ushio Y; Kochi M; Kitamura I; Kuratsu J
J Neurooncol; 1998; 38(2-3):207-12. PubMed ID: 9696373
[TBL] [Abstract][Full Text] [Related]
22. [Intrathecal infusion of the antineoplastic agents for meningeal dissemination].
Hodozuka A; Hayashi Y; Annei R; Hiroshima S; Saito M; Orimoto R; Sato M; Tanaka T
Gan To Kagaku Ryoho; 2008 Jun; 35(6):900-5. PubMed ID: 18633217
[TBL] [Abstract][Full Text] [Related]
23. Interaction of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitroso urea hydrochloride with nucleic acids and proteins.
Nishigaki T; Tanaka M
Chem Biol Interact; 1985 Dec; 56(2-3):213-24. PubMed ID: 2416482
[TBL] [Abstract][Full Text] [Related]
24. [Intrathecal perfusion of ACNU neurotoxicity and intrathecal pharmacokinetics in dogs].
Kochi M; Kuratsu J; Mihara Y; Inoue N; Takaki S; Sueyoshi N; Soyama N; Uemura S; Ushio Y
No Shinkei Geka; 1989 Aug; 17(8):741-6. PubMed ID: 2586715
[TBL] [Abstract][Full Text] [Related]
25. [Effect of ACNU against experimental brain tumor--immunohistochemical study using anti-BrdU monoclonal antibody].
Izumoto S; Arita N; Ushio Y; Hayakawa T; Yoshimine T; Tzuu-Yuan H; Nagatani M; Oku Y; Mogami H
No To Shinkei; 1988 Nov; 40(11):1095-9. PubMed ID: 3219244
[TBL] [Abstract][Full Text] [Related]
26. [ACNU delivery to malignant tumor tissue and serum--route of administration and combined use of phenobarbital].
Muraoka K
No To Shinkei; 1983 Dec; 35(12):1199-206. PubMed ID: 6584117
[TBL] [Abstract][Full Text] [Related]
27. Modulation of BUdR labeling index in rat brain tumors following intracarotid ACNU administration.
Mineura K; Watanabe K; Izumi I; Kowada M
J Neurooncol; 1992 Nov; 14(3):201-5. PubMed ID: 1460484
[TBL] [Abstract][Full Text] [Related]
28. Isolation and preliminary characterization of ACNU-resistant sublines of rat brain tumors in vivo.
Yoshida TK; Shimizu K; Koulousakis A; Sturm V; Beuls E
J Neurosurg; 1992 Sep; 77(3):451-6. PubMed ID: 1506893
[TBL] [Abstract][Full Text] [Related]
29. Potentiation of therapeutic effects of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride by 6-thioguanine in mouse tumor systems: comparison with other antimetabolites.
Fujimoto S; Ogawa M; Hoshino A
Gan; 1980 Feb; 71(1):60-72. PubMed ID: 6929770
[TBL] [Abstract][Full Text] [Related]
30. Prediction of ACNU plasma concentration-time profiles in humans by animal scale-up.
Mitsuhashi Y; Sugiyama Y; Ozawa S; Nitanai T; Sasahara K; Nakamura K; Tanaka M; Nishimura T; Inaba M; Kobayashi T
Cancer Chemother Pharmacol; 1990; 27(1):20-6. PubMed ID: 2245489
[TBL] [Abstract][Full Text] [Related]
31. Distribution of radiolabeled 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitros ourea hydrochloride in rat brain tumor: intraarterial versus intravenous administration.
Yamada K; Ushio Y; Hayakawa T; Arita N; Huang TY; Nagatani M; Yamada N; Mogami H
Cancer Res; 1987 Apr; 47(8):2123-8. PubMed ID: 3470138
[TBL] [Abstract][Full Text] [Related]
32. Enhanced antitumor effect of combined-modality treatment using convection-enhanced delivery of hydrophilic nitrosourea with irradiation or systemic administration of temozolomide in intracranial brain tumor xenografts.
Sugiyama S; Yamashita Y; Kikuchi T; Sonoda Y; Kumabe T; Tominaga T
Neurol Res; 2008 Nov; 30(9):960-7. PubMed ID: 18671903
[TBL] [Abstract][Full Text] [Related]
33. [Pancreatic and biliary excretion of 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) in man].
Matsuno S; Kakizaki K; Sasaki K; Sato T
Gan To Kagaku Ryoho; 1983 Jun; 10(6):1486-90. PubMed ID: 6575728
[TBL] [Abstract][Full Text] [Related]
34. Timing of hypertonic glucose and thermochemotherapy with 1-(4-amino-2-methylpyrimidine-5-yl) methyl-3-(2-chloroethyl)-3-nitrosourea (ACNU) in the BT4An rat glioma: relation to intratumoral pH reduction and circulatory changes after glucose supply.
Schem BC; Roszinski S; Krossnes BK; Mella O
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):409-16. PubMed ID: 7673028
[TBL] [Abstract][Full Text] [Related]
35. [Studies on the mechanism of ACNU resistance in sublines of rat C6 glioma and 9L gliosarcoma in vitro].
Yoshida T; Shimizu K; Ushio Y; Hayakawa T; Kato A; Mogami H; Sakamoto Y
No Shinkei Geka; 1986 Oct; 14(11):1299-304. PubMed ID: 3468375
[TBL] [Abstract][Full Text] [Related]
36. Intrathecal ACNU treatment of B16 melanoma leptomeningeal metastasis in a new athymic rat model.
Schabet M; Ohneseit P; Buchholz R; Santo-Höltje L; Schmidberger H
J Neurooncol; 1992 Oct; 14(2):169-75. PubMed ID: 1432039
[TBL] [Abstract][Full Text] [Related]
37. Modulation in vitro and in vivo of ACNU resistance in a subline of C6 glioma with reserpine.
Yoshida T; Shimizu K; Ushio Y; Mogami H; Sakamoto Y
J Neurosurg; 1987 Feb; 66(2):251-5. PubMed ID: 3468207
[TBL] [Abstract][Full Text] [Related]
38. In vitro metabolism of ACNU, 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitroso urea hydrochloride, a water-soluble antitumor nitrosourea.
Nishigaki T; Nakamura K; Tanaka M
J Pharmacobiodyn; 1985 Jun; 8(6):409-16. PubMed ID: 3863922
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of ACNU cytotoxicity by pretreatment with O6-methylguanine in ACNU-resistant brain tumors.
Mineura K; Izumi I; Watanabe K; Kowada M
J Neurooncol; 1994; 19(1):51-9. PubMed ID: 7815104
[TBL] [Abstract][Full Text] [Related]
40. Antitumor activity and toxicity of ACNU, 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitroso urea hydrochloride, comparing two divided doses and a single dose.
Fujimoto S; Wang Y; Ogawa M
Cancer Chemother Pharmacol; 1984; 12(3):173-8. PubMed ID: 6584235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
